Improvements in survival for patients with stage IV adenocarcinoma in the lung, diagnosed between 2010 – 2020 - A population-based registry study from Norway

OBJECTIVES: We investigated how the prognosis for Norwegian patients with stage IV, adenocarcinoma (NSCLC) has developed during the last decade, to observe if increased survival coincides with the introduction of immunotherapy at a population level. MATERIALS AND METHODS: Incidence data from the Can...

Descripción completa

Detalles Bibliográficos
Autores principales: Børø, Siri, Thoresen, Steinar, Helland, Åslaug
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745181/
https://www.ncbi.nlm.nih.gov/pubmed/36523970
http://dx.doi.org/10.3389/fonc.2022.1017902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745181/
https://www.ncbi.nlm.nih.gov/pubmed/36523970
http://dx.doi.org/10.3389/fonc.2022.1017902

Ejemplares similares